Is Adherence to Imatinib Mesylate Treatment among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
Nader Al‐Dewik(St George's, University of London), Mohamed A. Yassin(Hamad Medical Corporation), Rola Ghasoub(National Center for Cancer Care and Research), Rana Al‐Jurf(Hamad Medical Corporation), Rani Khatib(University of Leeds), Tawfeg Ben‐Omran(Hamad General Hospital), Cinquea C. Gnanam(National Center for Cancer Care and Research), Ali A. Alsayab(Hamad Medical Corporation), Muthanna Samara(Kingston University), Mohammed Alsharshani(Hamad Medical Corporation), Abdulqadir J. Nashwan(Qatar Airways (Qatar)), Subi K. Bhaskaran(National Center for Cancer Care and Research), Mohamed A. Ismail(Hamad Medical Corporation), Hisham Morsi(St George's, University of London)
Cited by 39
Related Papers
Using thematic analysis in qualitative research
|Journal of Medicine Surgery and Public Health|2025|413
Knowledge, attitude, and practice of artificial intelligence among doctors and medical students in Syria: A cross-sectional online survey
|Frontiers in Artificial Intelligence|2022|164
Comparing the Impact of COVID-19 on Nurses’ Turnover Intentions before and during the Pandemic in Qatar
|Journal of Personalized Medicine|2021|148
Artificial intelligence-enhanced electrocardiography for accurate diagnosis and management of cardiovascular diseases
|Journal of Electrocardiology|2024|114